In the cardio-oncology population, drug interactions are of particular importance given the
complex pharmacological profile, narrow therapeutic index, and inherent risk of therapies …

Cancer patients have an increased risk of thrombosis. The development of cancer
thrombosis is dependent on a number of factors including cancer type, stage, various …

Disseminated intravascular coagulation (DIC) is characterized by the intravascular activation
of coagulation with loss of localization arising from different causes, and is diagnosed using …

Thrombosis represents a serious complication in patients affected by myeloid and lymphoid
acute leukemia. A proper knowledge of its pathophysiology and of the predisposing risk …

The incorporation of L-asparaginase and pegylated asparaginase into pediatric-inspired
regimens has conferred a survival advantage in treatment of adults with acute lymphoblastic …

Venous thromboembolism (VTE) is a common complication of hematopoietic stem cell
transplantation (HSCT) and its treatment has significant effects on morbidity and non-relapse …

The management of potentially life-threatening malignancies in pregnancy is complicated by
a lack of robust safety and efficacy evidence. This data shortage stems from a historical …

Thrombosis rates among young adults receiving asparaginase (ASP) for acute
lymphoblastic leukemia (ALL) can reach 34%, with highest risk during induction. Our …

Objectives Our review aims to present existing data on the safety of Intravenous
thrombolysis (IVT) use in acute ischemic stroke (AIS) patients with concomitant central …

Cancer remains a persistent global health concern, representing a significant challenge in
medical science and patient care. In this context, l‐asparaginase has emerged as a …